2021 TDDW Abstract Book

Page 24

2021 TDDW

Symposium (I) THIRD SPACE ENDOSCOPY – 2021 UPDATE

POEM FOR ESOPHAGEAL MOTILITY DISEASE. WHO, WHEN AND HOW? Yin-Yi Chu Ultrasonography and Endoscopy Center, New Taipei Municipal Tuchen Hospital, New Taipei City, Taiwan Department of Gastroenterology and Hepatology, Linkou Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan High-resolution manometry is now the gold standard diagnostic tool for esophageal motility diseases, which classified on the basis of lower esophageal sphincter (LES) relaxation and motility of esophageal body: (1) incomplete LES relaxation, including achalasia and EGJ outflow obstruction; (2) major motility disorders, including absent contractility, distal esophageal spasm etc.; (3) minor motility disorders; (4) normal esophageal motility. Third space endoscopy is based on the principle that the deeper layers of the gastrointestinal tract can be accessed by tunneling in the submucosal space and maintaining the integrity of the overlying mucosa. The era of third space endoscopy started

with peroral endoscopic myotomy (POEM) for treatment of achalasia and has expanded to treat various other gastrointestinal disorders. This topic focus on POEM application to various esophageal motility diseases, (1) the indications of POEM, including non-achalasia spastic esophageal motility disorders, the extreme of age and failed previous treatment of achalasia, (2) advancements in procedural techniques such as detection of EGJ and adequacy myotomy, length and site of myotomy, full thickness or circular myotomy, (3) the effectiveness, outcomes and advers events of POEM. Up to now, POEM is rapidly emerging as minimally invasive alternatives to conventional surgery.

21


Turn static files into dynamic content formats.

Create a flipbook

Articles inside

V) Cirrhosis & HCC

11min
pages 124-129

IV) Pancreas / Biliary

8min
pages 120-123

II) LGI

8min
pages 109-113

I) HCV

11min
pages 103-108

XV) Interventional Oncology in HCC

3min
pages 88-90

XVI) Small Bowel Lymphoma

18min
pages 91-102

XIV) HBV/HCC Symposiums

4min
pages 84-87

Pandemic

8min
pages 79-83

XII) Organ-Gut Axis: Innovation to Practice

6min
pages 74-78

X) Strategies to Improve Outcome for Gastric Cancer in Taiwan

5min
pages 66-69

IX) New Diagnostic Modalities in Digestive Diseases

7min
pages 62-65

National Scale

11min
pages 51-56

VIII) Interventional Oncology in Digestive Medicine

5min
pages 57-61

VI) First Line Combination Therapy or Sequential Therapy for HCC

5min
pages 47-50

V) Updates in the Treatment of Functional GI Disorder

9min
pages 42-46

IV) NASH Symposium

7min
pages 37-41

Pancreatic Cancer

6min
pages 29-33

I) Third Space Endoscopy – 2021 Update

8min
pages 24-28

Chicago 4.0

1min
page 10

V) Update Surgical Strategy toward Pancreatic Cancer in Japan

1min
page 9

IV) From Innovation to Clinical Practice: Co-creation Model and Case Study

1min
page 8

Metastatic Pancreatic Cancer

21min
pages 11-23

I) Colon Cancer: The Roles of Gut Microbiota

0
page 5

III) Emerging Trends of Inflammatory Bowel Disease in Asia

1min
page 7
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.